MA42036A - Analogues nucléosidiques 5'-substitués - Google Patents

Analogues nucléosidiques 5'-substitués

Info

Publication number
MA42036A
MA42036A MA042036A MA42036A MA42036A MA 42036 A MA42036 A MA 42036A MA 042036 A MA042036 A MA 042036A MA 42036 A MA42036 A MA 42036A MA 42036 A MA42036 A MA 42036A
Authority
MA
Morocco
Prior art keywords
nucleosid
analogues
substitute
substitute nucleosid
nucleosid analogues
Prior art date
Application number
MA042036A
Other languages
English (en)
Inventor
Zahid Quyoom Bonday
Guillermo S Cortez
Karl Robert Dahnke
Michael John Grogan
Antonio Rodriguez HERGUETA
James Andrew Jamison
Brian Morgan Watson
Timothy Andrew Woods
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of MA42036A publication Critical patent/MA42036A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/14—Pyrrolo-pyrimidine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/10—Drugs for disorders of the urinary system of the bladder
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
    • A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
    • A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
    • A61K31/7076—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines containing purines, e.g. adenosine, adenylic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Endocrinology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Saccharide Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
MA042036A 2015-05-04 2016-04-27 Analogues nucléosidiques 5'-substitués MA42036A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP15382225 2015-05-04

Publications (1)

Publication Number Publication Date
MA42036A true MA42036A (fr) 2018-03-14

Family

ID=53177322

Family Applications (1)

Application Number Title Priority Date Filing Date
MA042036A MA42036A (fr) 2015-05-04 2016-04-27 Analogues nucléosidiques 5'-substitués

Country Status (25)

Country Link
US (1) US9840532B2 (fr)
EP (1) EP3292128A1 (fr)
JP (2) JP6181889B1 (fr)
KR (1) KR20170132871A (fr)
CN (1) CN107580602A (fr)
AR (1) AR104326A1 (fr)
AU (1) AU2016258485A1 (fr)
BR (1) BR112017020336A2 (fr)
CA (1) CA2981097A1 (fr)
CL (1) CL2017002637A1 (fr)
CO (1) CO2017010727A2 (fr)
CR (1) CR20170443A (fr)
DO (1) DOP2017000255A (fr)
EA (1) EA201792169A1 (fr)
EC (1) ECSP17072987A (fr)
HK (1) HK1244007A1 (fr)
IL (1) IL254409A0 (fr)
MA (1) MA42036A (fr)
MX (1) MX2017014001A (fr)
PE (1) PE20180231A1 (fr)
PH (1) PH12017502002A1 (fr)
SG (1) SG11201708345XA (fr)
TN (1) TN2017000459A1 (fr)
TW (1) TWI615400B (fr)
WO (1) WO2016178870A1 (fr)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA031895B1 (ru) * 2015-02-24 2019-03-29 Пфайзер Инк. Замещенные нуклеозидные производные, полезные в качестве агентов против рака
WO2018139181A1 (fr) * 2017-01-27 2018-08-02 国立大学法人 宮崎大学 Agent anticancéreux, procédé de criblage pour agent anticancéreux, kit de détermination de l'efficacité sur le cancer et procédé de détermination de l'efficacité sur le cancer
WO2018152548A1 (fr) 2017-02-20 2018-08-23 Prelude Therapeutics, Incorporated Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5)
WO2018152501A1 (fr) 2017-02-20 2018-08-23 Prelude Therapeutics, Incorporated Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5)
WO2018160855A1 (fr) 2017-03-01 2018-09-07 Prelude Therapeutics, Incorporated Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5)
MA49840A (fr) * 2017-08-09 2020-06-17 Prelude Therapeutics Inc Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5)
EP3700906A1 (fr) 2017-10-26 2020-09-02 Prelude Therapeutics, Incorporated Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5 (prmt5)
CR20200263A (es) 2017-12-13 2020-07-26 Lupin Ltd Componentes heterocíclicos bicíclicos sustituidos como inhibidores de prmt5
CA3092357A1 (fr) 2018-03-14 2019-09-19 Prelude Therapeutics, Incorporated Inhibiteurs selectifs de la proteine arginine methyltransferase 5 (prmt5)
JP7337539B2 (ja) * 2018-06-21 2023-09-04 メディヴィル・アクチエボラーグ 白血病療法のための塩基修飾シチジンヌクレオチド
WO2020033285A1 (fr) * 2018-08-07 2020-02-13 Merck Sharp & Dohme Corp. Inhibiteurs de prmt5
US20220160713A1 (en) * 2019-02-13 2022-05-26 Prelude Therapeutics, Incorporated Selective inhibitor of protein arginine methyltransferase 5 (prmt5)
WO2020206299A1 (fr) 2019-04-05 2020-10-08 Prelude Therapeutics, Incorporated Inhibiteurs sélectifs de la protéine arginine méthyltransférase 5
CR20220010A (es) 2019-06-10 2022-05-13 Lupin Ltd Inhibidores de prmt5
CA3154566A1 (fr) 2019-09-18 2021-03-25 Prelude Therapeutics Incorporated Inhibiteurs selectifs de la proteine arginine methyltransferase 5 (prmt5)
GEP20247638B (en) 2019-10-22 2024-07-10 Lupin Ltd Pharmaceutical combination of prmt5 inhibitors
EP4069698A1 (fr) 2019-12-03 2022-10-12 Lupin Limited Analogues nucléosidiques substitués en tant qu'inhibiteurs de prmt5
GB202117230D0 (en) 2021-11-29 2022-01-12 Argonaut Therapeutics Ltd Peptide vaccine
GB202203588D0 (en) 2022-03-15 2022-04-27 Argonaut Therapeutics Ltd Cancer diagnostic
CN116211869B (zh) * 2022-12-07 2023-08-01 浙江省肿瘤医院 含dna损伤修复抑制剂的药物混合物及混合方法、用途
WO2026008533A1 (fr) 2024-07-01 2026-01-08 Janssen Pharmaceutica Nv Inhibiteurs de prmt5 pour le traitement d'adénomes

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL354094A1 (en) * 1999-08-27 2003-12-29 Icn Pharmaceuticals, Inc.Icn Pharmaceuticals, Inc. Pyrrolo[2,3-d]pyrimidine nucleoside analogs
NZ544187A (en) * 2005-12-15 2008-07-31 Ind Res Ltd Deazapurine analogs of 1'-aza-l-nucleosides
WO2011079236A1 (fr) 2009-12-22 2011-06-30 The Ohio State University Research Foundation Compositions et méthodes de détection et de traitement du cancer
WO2013009735A1 (fr) 2011-07-13 2013-01-17 Merck Sharp & Dohme Corp. Dérivés de nucléosides 5'-substitués et leurs procédés d'utilisation pour le traitement de maladies virales
WO2014100764A2 (fr) 2012-12-21 2014-06-26 Epizyme, Inc. Procédés d'inhibition de prmt5
US9604930B2 (en) 2012-12-21 2017-03-28 Epizyme, Inc. Tetrahydro- and dihydro-isoquinoline PRMT5 inhibitors and uses thereof
US10118918B2 (en) 2012-12-21 2018-11-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US9365555B2 (en) * 2012-12-21 2016-06-14 Epizyme, Inc. PRMT5 inhibitors and uses thereof
US9908887B2 (en) 2012-12-21 2018-03-06 Epizyme, Inc. PRMT5 inhibitors and uses thereof
JP2016505002A (ja) 2012-12-21 2016-02-18 エピザイム，インコーポレイティド ジヒドロイソキノリンまたはテトラヒドロイソキノリンを含有するｐｒｍｔ５阻害剤およびその使用
EA031895B1 (ru) * 2015-02-24 2019-03-29 Пфайзер Инк. Замещенные нуклеозидные производные, полезные в качестве агентов против рака

Also Published As

Publication number Publication date
WO2016178870A1 (fr) 2016-11-10
MX2017014001A (es) 2018-03-16
CA2981097A1 (fr) 2016-11-10
TN2017000459A1 (en) 2019-04-12
JP2017125029A (ja) 2017-07-20
US20160326208A1 (en) 2016-11-10
ECSP17072987A (es) 2018-02-28
AR104326A1 (es) 2017-07-12
EP3292128A1 (fr) 2018-03-14
TW201712022A (zh) 2017-04-01
JP6181889B1 (ja) 2017-08-16
CO2017010727A2 (es) 2018-01-31
US9840532B2 (en) 2017-12-12
JP2017525667A (ja) 2017-09-07
CN107580602A (zh) 2018-01-12
KR20170132871A (ko) 2017-12-04
IL254409A0 (en) 2017-11-30
SG11201708345XA (en) 2017-11-29
EA201792169A1 (ru) 2018-03-30
TWI615400B (zh) 2018-02-21
DOP2017000255A (es) 2018-01-15
PE20180231A1 (es) 2018-01-31
CL2017002637A1 (es) 2018-04-20
PH12017502002A1 (en) 2018-03-26
BR112017020336A2 (pt) 2019-05-14
AU2016258485A1 (en) 2017-10-12
CR20170443A (es) 2017-11-07
HK1244007A1 (zh) 2018-07-27

Similar Documents

Publication Publication Date Title
MA46180A (fr) Analogues de l'amyline
LT3298027T (lt) Antihelmintiniai depsipeptido junginiai
EP3364956A4 (fr) Analogues de célastrol
EP3718392A4 (fr) Moissonneuse
LT3386954T (lt) Dimeriniai kontrastiniai agentai
KR20180084876A (ko) 내플라즈마성 부재
EP3345473A4 (fr) Moissonneuse-batteuse
EP3351087A4 (fr) Moissonneuse-batteuse
EP3476198A4 (fr) Moissonneuse-batteuse
EP3272204A4 (fr) Moissonneuse-batteuse
EP3407974A4 (fr) Analogues d'amlexanox
EP3332776A4 (fr) Timbre transdermique
EP3168671C0 (fr) Arrangement d'illumination
IT201700103032A1 (it) Moschettone
UA32431S (uk) Стрем'янка
ITUB201551290U1 (it) Ovie' oviel
DK3426641T3 (da) Immunoproteasominhibitoranaloger
FI11845U1 (fi) Hengityssuoja
FI11901U1 (fi) Paistinlasta
FR3041379B1 (fr) Turbopropulseur d'aeronef
IT201700090331A1 (it) "lopemide"
IT201700071679A1 (it) Remembebe'
ITUA20163709A1 (it) "presentosa3d"
FR3036257B3 (fr) "chaussure"
UA31878S (uk) Стіл-трансформер «sріdеr»